Chest pain, swelling in one leg, or sudden shortness of breath need emergency care. Call 911 or your local emergency number instead of waiting for a scheduled lab draw.
Hematocrit is the share of your total blood volume made up of red blood cells, reported as a percentage on a complete blood count. Hematocrit is the single marker most closely watched on testosterone therapy, because the hormone pushes the bone marrow to make more red cells. Typical lab reference ranges run roughly 36 to 52 % in men and 33 to 48 % in women. FitScript's optimal range is 40 to 50 % in men and 36 to 44 % in women. Optimal ranges are FitScript's optimization targets, not diagnostic cut-offs, and standard reference ranges vary by lab, age and sex. The sample is a routine venous draw, usually taken alongside the rest of a panel. The biomarker guide covers how the test is run and how a result is read in full.
The effects reported most often are a rise in red blood cell concentration, acne and oilier skin, fluid retention, breast or nipple tenderness, higher blood pressure readings, worsening of sleep apnea in people prone to it, and suppression of the body's own hormone signalling. A systematic review and meta-analysis of adverse effects in adult men reported that a rise in red cell concentration is associated with testosterone therapy more consistently than any other single effect 1.
Most of these are gradual and detectable on routine monitoring before they become obvious to the person taking the therapy. That is the central practical point of this page. Side effects on testosterone therapy are mostly a monitoring problem rather than a guessing problem, because the markers that move are measurable and cheap to measure.
People usually start therapy after symptoms plus repeated morning blood draws point toward low testosterone in men, and a licensed provider evaluates whether therapy is appropriate in the first place. The same provider decides what to do about any effect that shows up later.
| What you may notice | What it may reflect | How it is usually tracked |
|---|---|---|
| Blood that thickens over months | Increased red cell production | Hematocrit and hemoglobin on a complete blood count |
| Acne, oilier skin, scalp changes | Androgen effect on oil glands and hair follicles | Skin and scalp review at follow-up |
| Puffy ankles, rings or shoes feeling tight | Sodium and water retention | Weight trend, swelling check, blood pressure |
| Breast or nipple tenderness | Shift in the testosterone to estradiol balance | Estradiol measured with a sensitive assay |
| Louder snoring, daytime sleepiness | Possible worsening of sleep apnea | Symptom review, sleep study if a clinician orders one |
| Higher blood pressure readings | Fluid shifts plus thicker blood | Home and clinic blood pressure readings |
| Urinary changes | Prostate related, with several possible causes | PSA and symptom review |
| Smaller testicles, lower sperm production | Suppressed signalling from the brain to the testes | LH, FSH and testosterone |
Testosterone stimulates red blood cell production, so more circulating testosterone generally means more red cells per unit of blood. Two mechanisms are usually described. Testosterone raises the signal the kidneys send to the bone marrow to produce red cells, and it lowers hepcidin, the hormone that restricts how much iron is released into circulation. More iron available plus a stronger production signal means a higher red cell mass over time. Reviews of testosterone therapy in older men describe this rise in red cell concentration as the most frequent laboratory change seen on therapy 23.
What that means in practice is a slow upward drift in hematocrit and hemoglobin across repeat panels, rather than a sudden jump. Thicker blood is harder to pump and flows less easily through small vessels, which is why clinicians pay attention to the trend rather than to a single value.
A rising hematocrit does not automatically point at the therapy. Dehydration at the time of the draw inflates the number, because hematocrit is a concentration rather than a count. Smoking, living at altitude, chronic lung conditions and unmanaged sleep apnea all push red cell production up independently. Observation, a value above your usual baseline. Possible meaning, more red cell mass or simply a concentrated sample. Next step, bring the trend to the prescribing clinician, who decides whether to repeat the draw and what follows.
It can, which is why blood pressure belongs on the monitoring list alongside bloodwork. Several mechanisms plausibly contribute. Sodium and water retention expands blood volume, a higher red cell concentration increases blood viscosity, and worsened sleep apnea raises overnight and daytime pressure in people who have it.
The practical version is simple. A single clinic reading taken after rushing through traffic tells you very little. A pattern of readings taken at home, sitting, feet flat, arm supported, over a week or two, tells you a lot. If readings climb from your established baseline after starting therapy, that is worth discussing with a clinician promptly rather than at the next scheduled visit.
Blood pressure is also one of the few markers on this list you can watch between lab draws without a needle. That makes it a useful early warning for fluid retention, which tends to show up as weight gain over a few days, tighter rings and swollen ankles at the same time. Some medicines also affect blood pressure. Ask your prescriber about anything else you take rather than adjusting anything yourself.
Yes, and these are among the effects reported most often in the first months. Androgens increase sebum production in the skin's oil glands, which can produce oilier skin, blocked pores and acne on the face, chest, shoulders and back. A systematic review and meta-analysis of adverse effects in adult men included acne among the effects reported on testosterone therapy 1.
Hair follows the same hormonal logic in the opposite direction. Body hair tends to increase, while scalp hair can thin in people genetically predisposed to pattern hair loss, because the scalp follicle responds to androgen signalling differently from the follicles on the rest of the body. Predisposition matters more than the therapy itself here, which is why two people on comparable therapy can have completely different experiences.
Skin and hair effects are cosmetic rather than a marker of harm, but they are worth reporting because they often track the overall hormonal picture. Treatment decisions belong to a licensed provider, including anything applied to the skin or taken by mouth. Nothing on this page should be used to start or change a product on your own.
Fluid retention shows up as puffiness around the ankles and feet, rings and watch straps feeling tight, mild facial puffiness in the morning, and a weight gain of a few pounds over days rather than weeks. It happens because androgens influence how the kidneys handle sodium, and where sodium goes, water follows.
Mild, symmetrical swelling that settles overnight is usually described as a nuisance effect. Reviews of testosterone therapy list fluid retention among the effects that warrant attention, particularly in people with heart or kidney conditions, where extra volume is harder to clear 34. In people with those conditions, a provider weighs this carefully before therapy starts.
The pattern matters more than the presence of swelling. Swelling in both legs that comes and goes is different from swelling in one leg that appears suddenly, which, together with chest pain or sudden shortness of breath, needs emergency care rather than a message to your clinic. Daily weight taken at the same time each morning is the cheapest tracker for this, and a jump of several pounds in a few days without a change in eating is worth flagging to your clinician promptly.
It can in people who already have obstructive sleep apnea or who are at risk of it, which is why sleep is part of a proper intake conversation. Research suggests that worsening of obstructive sleep apnea is among the risks discussed when testosterone therapy is considered in older men 5, and reviews of therapy in hypogonadal men include sleep apnea among the effects monitored during follow-up 3.
The signs are easy to miss from the inside. Loud snoring, pauses in breathing noticed by a partner, waking unrefreshed, morning headaches, and daytime sleepiness that coffee does not fix are the usual ones. A sleep study is the only way to confirm it, and whether one is ordered is a clinical decision.
Sleep apnea also connects back to the first section of this page. Repeated drops in overnight oxygen push the body to make more red cells, so unmanaged apnea and testosterone therapy can nudge hematocrit upward together. If hematocrit is drifting up and you snore heavily, those two facts belong in the same conversation with your clinician rather than in separate ones.
Some testosterone converts into estradiol through the aromatase enzyme, mostly in fat tissue, so raising testosterone usually raises estradiol as well. That is normal physiology rather than a malfunction. Estradiol has real jobs in men, including roles in bone density, libido and mood, so the goal described in clinical reviews is balance rather than suppression.
When the testosterone to estradiol balance shifts far enough, people may notice breast or nipple tenderness, visible breast tissue change, fluid retention, or mood swings. Symptoms at the low end can look surprisingly similar, including joint discomfort, low libido and flat mood, which is why a symptom alone does not tell you which direction things have moved.
Measurement quality matters here. Estradiol in men sits at the low end of what some immunoassays measure reliably, so a sensitive assay is generally preferred for monitoring. Observation, a shifted estradiol with new breast tenderness. Possible meaning, more aromatization than your previous balance. Next step, discuss the result and symptoms with the prescribing clinician, who decides whether anything changes. Managing estradiol is a prescribing decision and belongs to a licensed provider.
The cardiovascular picture is the most discussed and least settled part of this topic, and it is the reason blood pressure, lipids and hematocrit are monitored together. A systematic review and meta-analysis of exogenous testosterone use among men reported mixed findings on cardiovascular events across the studies it pooled 6. Research on testosterone therapy and cardiovascular disease in older hypogonadal men continues to be reviewed with attention to both potential benefits and potential risks 7.
An evidence report prepared for a clinical practice guideline on testosterone treatment in men found the evidence on cardiovascular outcomes to be limited 8. Reviews of therapy in men with age-related decline in testosterone similarly present cardiovascular safety as a question weighed case by case rather than answered for everyone 9.
What this means for you is neither reassurance nor alarm. It means the markers that plausibly connect therapy to the cardiovascular system, blood viscosity reflected in hematocrit, blood pressure, and lipids, are tracked on purpose and reviewed as a set. It also means that your own baseline risk, including family history, smoking, blood pressure and metabolic markers, carries more weight in the decision than any single headline. A licensed provider evaluates all of that before and during therapy.
PSA, prostate-specific antigen, is a blood marker produced by prostate tissue, and it is checked at baseline and monitored during therapy as part of standard follow-up. Reviews of testosterone treatment in older men with hypogonadism describe prostate monitoring, including PSA alongside symptom review, as part of routine safety follow-up 34.
PSA moves for many ordinary reasons. It rises with age and prostate size, after recent ejaculation, after vigorous cycling, with prostate inflammation, and after certain procedures. A single number in isolation is not interpretable, which is why clinicians look at the baseline value, the rate of change across draws, and urinary symptoms together.
Urinary symptoms worth reporting include a weaker stream, hesitancy, needing to go more often at night, and a sense of incomplete emptying. Observation, a PSA that has moved from your baseline. Possible meaning, several, most of them unrelated to therapy. Next step, do not interpret it yourself and do not ignore it. A clinician decides whether the result needs repeating or further assessment.
Several markers move predictably enough that they appear on most monitoring panels. Hemoglobin moves with hematocrit, since both reflect red cell mass. Ferritin and iron markers often drift down, because sustained red cell production consumes iron. LH and FSH, the pituitary signals that tell the testes to make testosterone, fall because the brain reads the external hormone as sufficient, which is why testicular size and the body's own production decline on therapy.
Lipids are worth watching as a trend. Research suggests that testosterone therapy can be associated with changes in lipid measures, with results differing across studies 1. Metabolic markers including fasting glucose and HbA1c are often tracked as well, partly because body composition changes on therapy and partly because they sit on the same cardiovascular risk map as blood pressure.
Liver and kidney chemistry usually appear on the same panel, less because they routinely shift and more because they establish a baseline against which any future change can be read. The value of all of this is in the series, not the snapshot. One panel tells you where you are. Four panels over time tell you where you are going, which is the information a clinician actually uses.
Monitoring combines bloodwork, blood pressure and a symptom review, and the prescribing clinician sets which markers are drawn and how often. The table below is the general shape of what gets watched and why.
| Marker or check | What it tracks | Why it is on the list |
|---|---|---|
| Hematocrit and hemoglobin | Red cell concentration | The most frequent laboratory change on therapy |
| Total testosterone | Circulating hormone level | Confirms where the level sits relative to the target a clinician set |
| Free testosterone and SHBG | The fraction available to tissues | Explains symptoms when total testosterone looks unremarkable |
| Estradiol, sensitive assay | Conversion of testosterone to estradiol | Links to breast tenderness, fluid and mood changes |
| LH and FSH | Pituitary signalling to the testes | Shows the degree of suppression of the body's own production |
| PSA and urinary symptoms | Prostate related monitoring | Part of standard safety follow-up |
| Blood pressure | Pressure trend at home and in clinic | Detects fluid and viscosity related change between draws |
| Lipid panel | Cholesterol and triglyceride trend | Sits alongside blood pressure on the cardiovascular picture |
| Ferritin and iron studies | Iron availability and stores | Red cell production draws on iron |
| Comprehensive metabolic panel | Kidney, liver and electrolyte baseline | Context for interpreting everything else |
The companion guide on how testosterone therapy works covers the mechanics and the monitoring rhythm in more detail. FitScript's membership tests 150+ biomarkers per year and has Atlas, FitScript's AI health advisor, interpret the results, with any treatment decision made by a licensed provider after reviewing the member.
Risk is not evenly distributed, and a good intake conversation is largely an exercise in finding out where you sit. A higher baseline hematocrit leaves less headroom before therapy pushes the value above the standard range. Unmanaged sleep apnea, smoking and living at high altitude all raise red cell production on their own. Excess body fat increases the tissue where testosterone converts to estradiol. Age matters too, and reviews of therapy in older men weigh the balance of potential benefit and potential risk differently than in younger men 29.
Hydration and timing shape the numbers you see. A draw taken dehydrated, after a sauna or a long training session, concentrates the blood and inflates hematocrit. Standardizing your draws, same time of day, similar hydration, before training rather than after, removes a lot of false signal from your trend line.
Other conditions change the calculus. In people with heart failure, kidney disease or a history of blood clots, fluid retention and thicker blood carry more weight in the decision, and a licensed provider evaluates whether therapy is appropriate at all. Some medicines also influence these markers. Ask your prescriber about everything you take, including anything bought without a prescription.
Start by not treating one value as a verdict. A result outside the standard lab range is a prompt to look closer, not a diagnosis, and a suboptimal number on one draw may simply reflect the conditions of that draw. The useful question is whether the value has moved from your own baseline across repeat panels.
Send the result to the clinician who prescribed the therapy, along with context. What time the draw was taken, how hydrated you were, whether you trained beforehand, how you have been sleeping, what your home blood pressure readings look like, and any new symptoms. That context often changes how a number is read.
Do not stop, pause or change anything on your own, and do not ignore an out-of-range result either. Both are decisions that belong with the prescribing clinician, who can compare the value to your history and to the rest of the panel. If the clinic is slow to respond and the value is well outside the standard range, say so plainly and ask for it to be reviewed promptly.
Book a conversation for anything persistent or new. Blood pressure readings that stay elevated at home, swelling that does not settle overnight, breast tenderness or visible breast change, heavy snoring or daytime sleepiness, headaches, mood changes that people around you notice, urinary changes, or acne that bothers you. None of those need to wait for the next scheduled panel.
Contact a clinician promptly, rather than at the next visit, for a hematocrit that has climbed well above the standard range, blood pressure readings that stay high across several days, or swelling with breathlessness on exertion. Chest pain, swelling in one leg, or sudden shortness of breath need emergency care. Call 911.
This article is educational and is not medical advice. Discuss your results, your symptoms and any treatment decision with a clinician or licensed provider who knows your history, since they are the only person who can interpret your numbers in the context of your health.
A rise in red blood cell concentration, seen as hematocrit and hemoglobin climbing across repeat panels. It is usually gradual rather than sudden, which is why the trend matters more than one value. Hydration and draw timing can also inflate a single reading, so your clinician will look at the pattern.
Timing varies a lot between people, and some changes show up on bloodwork before you notice anything. Skin changes and fluid retention tend to be noticed earlier, while red cell concentration usually drifts up over months. Your prescribing clinician sets the schedule for recheck labs and blood pressure readings.
It can in some people, which is why blood pressure is checked before starting and monitored afterwards. Fluid retention, thicker blood and worsened sleep apnea can all contribute. Home readings taken sitting with your arm supported over a week give a far more useful picture than one clinic reading.
Any decision about lowering a high hematocrit belongs to the clinician who prescribed your therapy, not to a result you read on your own. Bring the value and your recent draw conditions to them. Do not stop or change your therapy independently, and do not ignore an out-of-range result either.
Some testosterone converts to estradiol, so levels usually rise when testosterone rises. Estradiol has real roles in bone, libido and mood, so the aim is balance rather than the lowest possible number. A sensitive assay is generally preferred, since male estradiol sits at the low end of what some tests measure reliably.
Skin changes generally track your hormonal picture, so they often shift when that picture changes. They are a cosmetic effect rather than a sign of harm, but they are worth reporting at follow-up. Anything you might apply or take for it is a decision for a licensed provider.
Some effects settle once the hormonal picture changes, and others may take longer or persist. Only the clinician who knows your full history can judge what is likely in your case. Stopping or pausing therapy is a prescribing decision, not something to do on your own.
Chest pain, swelling in one leg, or sudden shortness of breath need emergency care. Call 911 or your local emergency number rather than waiting for a scheduled appointment or lab draw. Persistent high blood pressure readings or swelling that will not settle should be raised with your clinician promptly.